Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Reinhardt

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Scientific Reports|February 19, 2014
Optical spectroscopy of single Si nanocylinders with magnetic and electric resonancesAndrey B Evlyukhin, René L Eriksen, Wei Cheng, et al.
Nano Letters|April 8, 2014
The interplay between localized and propagating plasmonic excitations tracked in space and timeChristoph Lemke, Till Leissner, Andrey Evlyukhin, et al.
Urologia Internationalis|July 8, 2010
Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomyNorbert Marschner, Dominik Rüttinger, Gerhard Zugmaier, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 14, 2009
Three-dimensional biodegradable structures fabricated by two-photon polymerizationFrederik Claeyssens, Erol A Hasan, Arune Gaidukeviciute, et al.
Nano Letters|February 26, 2013
Spatiotemporal characterization of SPP pulse propagation in two-dimensional plasmonic focusing devicesChristoph Lemke, Christian Schneider, Till Leißner, et al.
Science (New York, N.Y.)|August 16, 2008
Tumor regression in cancer patients by very low doses of a T cell-engaging antibodyRalf Bargou, Eugen Leo, Gerhard Zugmaier, et al.
Optics Letters|July 2, 2013
Nanostripe length dependence of plasmon-induced material deformationsVentsislav K Valev, Wim Libaers, Urs Zywietz, et al.
The Lancet. Oncology|October 11, 2016
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trialBrian I Rini, Arnulf Stenzl, Romauld Zdrojowy, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 10, 2012
Plasmon-enhanced sub-wavelength laser ablation: plasmonic nanojetsVentsislav K Valev, Denitza Denkova, Xuezhi Zheng, et al.
Nature Medicine|May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trialMartin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Scientific Reports|February 19, 2014
Optical spectroscopy of single Si nanocylinders with magnetic and electric resonancesAndrey B Evlyukhin, René L Eriksen, Wei Cheng, et al.
Nano Letters|April 8, 2014
The interplay between localized and propagating plasmonic excitations tracked in space and timeChristoph Lemke, Till Leissner, Andrey Evlyukhin, et al.
Urologia Internationalis|July 8, 2010
Phase II study of the human anti-epithelial cell adhesion molecule antibody adecatumumab in prostate cancer patients with increasing serum levels of prostate-specific antigen after radical prostatectomyNorbert Marschner, Dominik Rüttinger, Gerhard Zugmaier, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|May 14, 2009
Three-dimensional biodegradable structures fabricated by two-photon polymerizationFrederik Claeyssens, Erol A Hasan, Arune Gaidukeviciute, et al.
Nano Letters|February 26, 2013
Spatiotemporal characterization of SPP pulse propagation in two-dimensional plasmonic focusing devicesChristoph Lemke, Christian Schneider, Till Leißner, et al.
Science (New York, N.Y.)|August 16, 2008
Tumor regression in cancer patients by very low doses of a T cell-engaging antibodyRalf Bargou, Eugen Leo, Gerhard Zugmaier, et al.
Optics Letters|July 2, 2013
Nanostripe length dependence of plasmon-induced material deformationsVentsislav K Valev, Wim Libaers, Urs Zywietz, et al.
The Lancet. Oncology|October 11, 2016
IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trialBrian I Rini, Arnulf Stenzl, Romauld Zdrojowy, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 10, 2012
Plasmon-enhanced sub-wavelength laser ablation: plasmonic nanojetsVentsislav K Valev, Denitza Denkova, Xuezhi Zheng, et al.
Nature Medicine|May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trialMartin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.
Pageof 5